Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in treating postmenopausal women-Reference-Cited by-同舟云学术

Safety assessment of compounded non-FDA-approved hormonal therapy versus FDA-approved hormonal therapy in treating postmenopausal women

Published:2021-05-10 Issue:8 Volume:28 Page:867-874
ISSN:1530-0374
Container-title:Menopause
language:en
Short-container-title:

Author:

Jiang Xuezhi,Bossert Anna,Parthasarathy K. Nathan,Leaman Kristine,Minassian Shahab S.,Schnatz Peter F.,Woodland Mark B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Earth and Planetary Sciences,General Environmental Science,Obstetrics and Gynecology

Reference23 articles.

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial;JAMA,2002

2. The NAMS 2017 hormone therapy position statement advisory panel. The 2017 hormone therapy position statement of The North American Menopause Society. North American Menopause Society;Menopause,2017

3. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial;LaCroix;JAMA,2011

4. Lessons learned from the women's health initiative trials of menopausal hormone therapy;Rossouw;Obstet Gynecol,2013

5. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials;Manson;JAMA,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are clinics not affiliated with a Menopause Society Certified Practitioner more likely to offer guideline-nonconcordant treatment compared to clinics affiliated with a Menopause Society Certified Practitioner?;Menopause;2024-07-08

2. Fear, misinformation, and pharmaceutical messianism in the promotion of compounded bioidentical hormone therapy;Frontiers in Reproductive Health;2024-02-29

3. An ethical assessment of compounded bioidentical hormone therapy;Climacteric;2024-01-30

4. Brazilian Guideline on Menopausal Cardiovascular Health – 2024;Arquivos Brasileiros de Cardiologia;2024

5. Diretriz Brasileira sobre a Saúde Cardiovascular no Climatério e na Menopausa – 2024;Arquivos Brasileiros de Cardiologia;2024